Back to Search Start Over

Sorafenib in combination with intensive chemotherapy for relapsed or refractory FLT3-ITD positive acute myeloid leukemia: A two centers experience.

Authors :
Urbino I
Secreto C
Apolito V
Olivi M
Arrigo G
Boscaro E
Catania FM
D'Ardia S
Frairia C
Giai V
Freilone R
Bruno B
Lanzarone G
Giaccone L
Busca A
Dellacasa CM
Ferrero D
Audisio E
Cerrano M
Source :
Leukemia research [Leuk Res] 2024 Jan; Vol. 136, pp. 107421. Date of Electronic Publication: 2023 Nov 18.
Publication Year :
2024

Abstract

Competing Interests: Declaration of Competing Interest None.

Subjects

Subjects :
Humans
fms-Like Tyrosine Kinase 3 genetics
Mutation
Niacinamide therapeutic use
Phenylurea Compounds therapeutic use
Protein Kinase Inhibitors therapeutic use
Sorafenib therapeutic use
Leukemia, Myeloid, Acute drug therapy
Leukemia, Myeloid, Acute genetics

Details

Language :
English
ISSN :
1873-5835
Volume :
136
Database :
MEDLINE
Journal :
Leukemia research
Publication Type :
Academic Journal
Accession number :
38042648
Full Text :
https://doi.org/10.1016/j.leukres.2023.107421
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details